UNSPSC 51294601: Minaprine

This classification denotes an antidepressant agent with the molecular formula C17H22N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00U7GX0NLM, chemically known as 4-morpholineethanamine, n- (4-methyl-6-phenyl-3-pyridazinyl)-, dihydrochloride but generally known as minaprine, which bears US NIH Compound Identifier 4199. European Medicines Agency schedules Minaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08974MIG.

UNSPSC 51294601 Minaprine, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities — Seminole County's procurement of naloxone and drug deactivation systems (IFB), Texas HHS's exploratory RFI on direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products — concern naloxone distribution, pharmacy benefit program restructuring, and broad-spectrum generic pharmaceutical supply respectively, none of which map to minaprine as a discrete pharmaceutical product. The code shows little relevant recent activity in state and local procurement when recent opportunities are examined against the code's nominal scope.

Activity across the identifiable opportunities spans multiple state and local bodies — a Florida county health department, a state HHS agency in Texas, and a multistate cooperative purchasing vehicle administered by Minnesota and serving Oregon — but the tagging of these opportunities under UNSPSC 51294601 appears to reflect misclassification or platform tagging error rather than genuine procurement demand for minaprine itself. Procurement professionals evaluating this code should verify whether minaprine purchases are actually being solicited under different codes or through established pharmaceutical supply frameworks before planning business development activities.